Zhejiang Province Excellent Enterprise Newspaper Jinhua City Excellent Internal Newspaper First Prize "Peak Newspaper" Won New Honor
Release time:
2022-09-27
News from this newspaper days ago, Zhejiang Enterprise Media Association announced the selection results of the province's outstanding enterprise media works and outstanding enterprise media (newspapers, periodicals and numbers) in 2021 . Jinhua Internal Press Association also held a meeting to commend the city's outstanding internal newspapers in 2021 , "Peak Newspaper" successively won the first prize of Zhejiang Excellent Enterprise Newspaper and Jinhua Excellent Internal Newspaper. News and supplement works published in 2021 also won many awards at the provincial and municipal levels.
According to different types of enterprise media, the outstanding enterprise media in Zhejiang Province in 2021 are selected by four types: enterprise newspaper, public number, internal publication and website. 38 enterprise newspapers including "Peak Newspaper" won the honor of outstanding enterprise newspaper in Zhejiang Province. In addition, among the news and supplement works published in the peak newspaper in 2021 , the chairman of the board of directors was happily shut out (no 32 , author: fu yiwu) won the first prize for news works. "Peak Cable, Embracing the Age of Rail Transit" (No. 32 , author: Chen Shengmu) won the second prize for news works; "From" Not Finished "to" Not Finished "Company Refined Technical Transformation Project Management (No. 23 13 , Author: Fu Yiwu)," Talk about Our Yunnan Peak Salesmen "(No. 25 22 , Author: Shang Yongzhen)," Huang Ping Peak Blowing "Pastoral Wind" (No. 27 25 , Author: chen Xiaomin), "Liu Jinpan: New Challenges for Old Salesmen" (No. 29 33 , author: Ni Yingzhen) won the third prize for news works; "Brave Doll" (No. 31 15 , author: Shi Fu) and "Unforgettable Journey" (No. 33 29 , author: Liu Hairong) won the supplement award. 2021 Jinhua City's excellent internal newspapers and periodicals are selected in two types: internal newspapers and internal periodicals. Peak Newspaper won the first prize for excellent internal newspapers. Ni Yingzhen and Chen Shengmu were also named 2021 Jinhua City's excellent internal newspapers and periodicals. In addition, "Jianfeng People's Heart is a Stranded Employee in Ejina" (No. 27
, author: Fu Yiwu) won the first prize for good news. "A Day in Shi Zhen Pavilion Pharmacy" (No.29 , author: Chen Shengmu) won the second prize for good news. "Huang Ping Peak Blowing" Pastoral Wind "won the third prize for good news." Question Bank Online, when you come to "War" (No. 23 , by Zhong Lijie), you will win the Good Title Award. No. 14 1 won the first prize for good layout (right picture); "Brave Doll" and "Unforgettable Journey" won the first prize and the second prize respectively for good supplements. (Reporter)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page